nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—schizophrenia—Lamotrigine—epilepsy syndrome	0.133	0.332	CpDpCtD
Mesoridazine—CHRM2—epilepsy syndrome	0.124	0.511	CbGaD
Mesoridazine—schizophrenia—Carbamazepine—epilepsy syndrome	0.101	0.252	CpDpCtD
Mesoridazine—schizophrenia—Valproic Acid—epilepsy syndrome	0.0859	0.214	CpDpCtD
Mesoridazine—schizophrenia—Clonazepam—epilepsy syndrome	0.0807	0.201	CpDpCtD
Mesoridazine—HTR2A—epilepsy syndrome	0.0621	0.256	CbGaD
Mesoridazine—CYP2D6—epilepsy syndrome	0.0568	0.234	CbGaD
Mesoridazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0285	0.116	CrCrCtD
Mesoridazine—Methdilazine—Carbamazepine—epilepsy syndrome	0.025	0.102	CrCrCtD
Mesoridazine—Promethazine—Carbamazepine—epilepsy syndrome	0.0236	0.0963	CrCrCtD
Mesoridazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0232	0.0945	CrCrCtD
Mesoridazine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0231	0.094	CrCrCtD
Mesoridazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0218	0.0887	CrCrCtD
Mesoridazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0214	0.0871	CrCrCtD
Mesoridazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.0213	0.0867	CrCrCtD
Mesoridazine—Promazine—Carbamazepine—epilepsy syndrome	0.02	0.0814	CrCrCtD
Mesoridazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0191	0.0779	CrCrCtD
Mesoridazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0184	0.075	CrCrCtD
Mesoridazine—HTR2A—phrenic nerve—epilepsy syndrome	0.00343	0.0866	CbGeAlD
Mesoridazine—DRD3—telencephalic ventricle—epilepsy syndrome	0.00261	0.0658	CbGeAlD
Mesoridazine—HTR6—ganglion—epilepsy syndrome	0.00156	0.0394	CbGeAlD
Mesoridazine—HTR2A—locus ceruleus—epilepsy syndrome	0.00153	0.0387	CbGeAlD
Mesoridazine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00145	0.0366	CbGeAlD
Mesoridazine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00125	0.0315	CbGeAlD
Mesoridazine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00122	0.0308	CbGeAlD
Mesoridazine—HTR2A—vagus nerve—epilepsy syndrome	0.00117	0.0296	CbGeAlD
Mesoridazine—DRD2—telencephalic ventricle—epilepsy syndrome	0.0011	0.0278	CbGeAlD
Mesoridazine—HTR2C—ganglion—epilepsy syndrome	0.000903	0.0228	CbGeAlD
Mesoridazine—HTR2A—pons—epilepsy syndrome	0.000884	0.0223	CbGeAlD
Mesoridazine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000815	0.0206	CbGeAlD
Mesoridazine—HTR1A—ganglion—epilepsy syndrome	0.00076	0.0192	CbGeAlD
Mesoridazine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000727	0.0184	CbGeAlD
Mesoridazine—DRD2—ganglion—epilepsy syndrome	0.000687	0.0173	CbGeAlD
Mesoridazine—HTR6—forebrain—epilepsy syndrome	0.000655	0.0165	CbGeAlD
Mesoridazine—HTR6—telencephalon—epilepsy syndrome	0.000603	0.0152	CbGeAlD
Mesoridazine—HTR1A—hindbrain—epilepsy syndrome	0.000576	0.0145	CbGeAlD
Mesoridazine—DRD2—hindbrain—epilepsy syndrome	0.000521	0.0131	CbGeAlD
Mesoridazine—HTR2A—ganglion—epilepsy syndrome	0.000453	0.0114	CbGeAlD
Mesoridazine—CHRM2—forebrain—epilepsy syndrome	0.000393	0.00991	CbGeAlD
Mesoridazine—HTR2C—brainstem—epilepsy syndrome	0.000392	0.0099	CbGeAlD
Mesoridazine—DRD3—head—epilepsy syndrome	0.00039	0.00983	CbGeAlD
Mesoridazine—HTR2C—forebrain—epilepsy syndrome	0.000379	0.00955	CbGeAlD
Mesoridazine—HTR6—head—epilepsy syndrome	0.000375	0.00947	CbGeAlD
Mesoridazine—DRD3—nervous system—epilepsy syndrome	0.00037	0.00932	CbGeAlD
Mesoridazine—CHRM2—telencephalon—epilepsy syndrome	0.000361	0.00911	CbGeAlD
Mesoridazine—DRD3—central nervous system—epilepsy syndrome	0.000356	0.00898	CbGeAlD
Mesoridazine—HTR6—nervous system—epilepsy syndrome	0.000356	0.00897	CbGeAlD
Mesoridazine—HTR2C—telencephalon—epilepsy syndrome	0.000348	0.00878	CbGeAlD
Mesoridazine—HTR2A—hindbrain—epilepsy syndrome	0.000343	0.00866	CbGeAlD
Mesoridazine—HTR6—central nervous system—epilepsy syndrome	0.000343	0.00864	CbGeAlD
Mesoridazine—HTR1A—brainstem—epilepsy syndrome	0.00033	0.00833	CbGeAlD
Mesoridazine—HTR1A—forebrain—epilepsy syndrome	0.000319	0.00804	CbGeAlD
Mesoridazine—CYP2D6—hindbrain—epilepsy syndrome	0.000313	0.00789	CbGeAlD
Mesoridazine—DRD2—brainstem—epilepsy syndrome	0.000298	0.00753	CbGeAlD
Mesoridazine—HTR1A—telencephalon—epilepsy syndrome	0.000293	0.00739	CbGeAlD
Mesoridazine—DRD2—forebrain—epilepsy syndrome	0.000288	0.00727	CbGeAlD
Mesoridazine—KCNH2—forebrain—epilepsy syndrome	0.000284	0.00716	CbGeAlD
Mesoridazine—DRD3—brain—epilepsy syndrome	0.000283	0.00713	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—epilepsy syndrome	0.000274	0.0069	CbGeAlD
Mesoridazine—HTR6—brain—epilepsy syndrome	0.000272	0.00686	CbGeAlD
Mesoridazine—DRD2—telencephalon—epilepsy syndrome	0.000265	0.00668	CbGeAlD
Mesoridazine—KCNH2—telencephalon—epilepsy syndrome	0.000261	0.00658	CbGeAlD
Mesoridazine—HTR2C—midbrain—epilepsy syndrome	0.00025	0.00631	CbGeAlD
Mesoridazine—HTR2C—spinal cord—epilepsy syndrome	0.000244	0.00615	CbGeAlD
Mesoridazine—HRH1—forebrain—epilepsy syndrome	0.000227	0.00574	CbGeAlD
Mesoridazine—CHRM2—head—epilepsy syndrome	0.000225	0.00568	CbGeAlD
Mesoridazine—HTR2C—head—epilepsy syndrome	0.000217	0.00547	CbGeAlD
Mesoridazine—CHRM2—nervous system—epilepsy syndrome	0.000213	0.00538	CbGeAlD
Mesoridazine—HTR1A—midbrain—epilepsy syndrome	0.000211	0.00531	CbGeAlD
Mesoridazine—HRH1—telencephalon—epilepsy syndrome	0.000209	0.00528	CbGeAlD
Mesoridazine—HTR2C—nervous system—epilepsy syndrome	0.000206	0.00519	CbGeAlD
Mesoridazine—HTR1A—spinal cord—epilepsy syndrome	0.000205	0.00518	CbGeAlD
Mesoridazine—CHRM2—central nervous system—epilepsy syndrome	0.000205	0.00518	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—epilepsy syndrome	0.000205	0.00517	CbGeAlD
Mesoridazine—HTR2C—central nervous system—epilepsy syndrome	0.000198	0.00499	CbGeAlD
Mesoridazine—HTR2A—brainstem—epilepsy syndrome	0.000197	0.00497	CbGeAlD
Mesoridazine—DRD2—midbrain—epilepsy syndrome	0.00019	0.0048	CbGeAlD
Mesoridazine—HTR2A—forebrain—epilepsy syndrome	0.00019	0.00479	CbGeAlD
Mesoridazine—KCNH2—midbrain—epilepsy syndrome	0.000187	0.00473	CbGeAlD
Mesoridazine—KCNH2—spinal cord—epilepsy syndrome	0.000183	0.00461	CbGeAlD
Mesoridazine—HTR1A—head—epilepsy syndrome	0.000183	0.0046	CbGeAlD
Mesoridazine—CYP2D6—brainstem—epilepsy syndrome	0.000179	0.00452	CbGeAlD
Mesoridazine—HTR2A—telencephalon—epilepsy syndrome	0.000175	0.00441	CbGeAlD
Mesoridazine—CYP2D6—forebrain—epilepsy syndrome	0.000173	0.00437	CbGeAlD
Mesoridazine—HTR1A—nervous system—epilepsy syndrome	0.000173	0.00437	CbGeAlD
Mesoridazine—HTR1A—central nervous system—epilepsy syndrome	0.000167	0.0042	CbGeAlD
Mesoridazine—DRD2—head—epilepsy syndrome	0.000165	0.00416	CbGeAlD
Mesoridazine—CHRM2—brain—epilepsy syndrome	0.000163	0.00411	CbGeAlD
Mesoridazine—HTR1A—cerebellum—epilepsy syndrome	0.000163	0.00411	CbGeAlD
Mesoridazine—KCNH2—head—epilepsy syndrome	0.000163	0.0041	CbGeAlD
Mesoridazine—CYP2D6—telencephalon—epilepsy syndrome	0.000159	0.00401	CbGeAlD
Mesoridazine—HTR2C—brain—epilepsy syndrome	0.000157	0.00396	CbGeAlD
Mesoridazine—DRD2—nervous system—epilepsy syndrome	0.000156	0.00394	CbGeAlD
Mesoridazine—KCNH2—nervous system—epilepsy syndrome	0.000154	0.00389	CbGeAlD
Mesoridazine—DRD2—central nervous system—epilepsy syndrome	0.000151	0.0038	CbGeAlD
Mesoridazine—KCNH2—central nervous system—epilepsy syndrome	0.000148	0.00374	CbGeAlD
Mesoridazine—DRD2—cerebellum—epilepsy syndrome	0.000147	0.00371	CbGeAlD
Mesoridazine—KCNH2—cerebellum—epilepsy syndrome	0.000145	0.00366	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—epilepsy syndrome	0.000137	0.00346	CbGeAlD
Mesoridazine—HTR1A—brain—epilepsy syndrome	0.000132	0.00334	CbGeAlD
Mesoridazine—HRH1—head—epilepsy syndrome	0.00013	0.00329	CbGeAlD
Mesoridazine—HTR2A—midbrain—epilepsy syndrome	0.000125	0.00316	CbGeAlD
Mesoridazine—HRH1—nervous system—epilepsy syndrome	0.000123	0.00311	CbGeAlD
Mesoridazine—HTR2A—spinal cord—epilepsy syndrome	0.000122	0.00309	CbGeAlD
Mesoridazine—DRD2—brain—epilepsy syndrome	0.00012	0.00301	CbGeAlD
Mesoridazine—HRH1—central nervous system—epilepsy syndrome	0.000119	0.003	CbGeAlD
Mesoridazine—KCNH2—brain—epilepsy syndrome	0.000118	0.00297	CbGeAlD
Mesoridazine—HTR2A—head—epilepsy syndrome	0.000109	0.00274	CbGeAlD
Mesoridazine—HTR2A—nervous system—epilepsy syndrome	0.000103	0.0026	CbGeAlD
Mesoridazine—HTR2A—central nervous system—epilepsy syndrome	9.93e-05	0.0025	CbGeAlD
Mesoridazine—CYP2D6—head—epilepsy syndrome	9.91e-05	0.0025	CbGeAlD
Mesoridazine—Metixene—CHRM3—epilepsy syndrome	9.81e-05	0.0334	CrCbGaD
Mesoridazine—HTR2A—cerebellum—epilepsy syndrome	9.71e-05	0.00245	CbGeAlD
Mesoridazine—HRH1—brain—epilepsy syndrome	9.44e-05	0.00238	CbGeAlD
Mesoridazine—CYP2D6—nervous system—epilepsy syndrome	9.4e-05	0.00237	CbGeAlD
Mesoridazine—Metixene—CHRM1—epilepsy syndrome	9.15e-05	0.0311	CrCbGaD
Mesoridazine—CYP2D6—central nervous system—epilepsy syndrome	9.05e-05	0.00228	CbGeAlD
Mesoridazine—CYP2D6—cerebellum—epilepsy syndrome	8.84e-05	0.00223	CbGeAlD
Mesoridazine—Ethopropazine—CHRM1—epilepsy syndrome	8.34e-05	0.0284	CrCbGaD
Mesoridazine—Cyamemazine—CHRM2—epilepsy syndrome	8.03e-05	0.0273	CrCbGaD
Mesoridazine—HTR2A—brain—epilepsy syndrome	7.88e-05	0.00199	CbGeAlD
Mesoridazine—Metixene—CHRM2—epilepsy syndrome	7.47e-05	0.0254	CrCbGaD
Mesoridazine—Eletriptan—HTR7—epilepsy syndrome	7.33e-05	0.0249	CrCbGaD
Mesoridazine—CYP2D6—brain—epilepsy syndrome	7.18e-05	0.00181	CbGeAlD
Mesoridazine—Mequitazine—CHRM2—epilepsy syndrome	6.98e-05	0.0237	CrCbGaD
Mesoridazine—Propericiazine—ADRA2A—epilepsy syndrome	6.86e-05	0.0233	CrCbGaD
Mesoridazine—Triflupromazine—CHRM1—epilepsy syndrome	6.83e-05	0.0232	CrCbGaD
Mesoridazine—Ethopropazine—CHRM2—epilepsy syndrome	6.81e-05	0.0232	CrCbGaD
Mesoridazine—Encainide—CYP2D6—epilepsy syndrome	6.71e-05	0.0228	CrCbGaD
Mesoridazine—Ethopropazine—BCHE—epilepsy syndrome	5.68e-05	0.0193	CrCbGaD
Mesoridazine—Triflupromazine—CHRM2—epilepsy syndrome	5.58e-05	0.019	CrCbGaD
Mesoridazine—Propiomazine—CHRM3—epilepsy syndrome	5.42e-05	0.0184	CrCbGaD
Mesoridazine—Propiomazine—CHRM1—epilepsy syndrome	5.05e-05	0.0172	CrCbGaD
Mesoridazine—Clemastine—CYP2D6—epilepsy syndrome	4.99e-05	0.017	CrCbGaD
Mesoridazine—Prochlorperazine—CHRM2—epilepsy syndrome	4.74e-05	0.0161	CrCbGaD
Mesoridazine—Triflupromazine—BCHE—epilepsy syndrome	4.65e-05	0.0158	CrCbGaD
Mesoridazine—Methotrimeprazine—CHRM3—epilepsy syndrome	4.63e-05	0.0158	CrCbGaD
Mesoridazine—Promethazine—CHRM3—epilepsy syndrome	4.56e-05	0.0155	CrCbGaD
Mesoridazine—Eletriptan—CYP2C19—epilepsy syndrome	4.54e-05	0.0155	CrCbGaD
Mesoridazine—Methotrimeprazine—CHRM1—epilepsy syndrome	4.32e-05	0.0147	CrCbGaD
Mesoridazine—Promethazine—CHRM1—epilepsy syndrome	4.26e-05	0.0145	CrCbGaD
Mesoridazine—Thiothixene—ADRA2A—epilepsy syndrome	4.24e-05	0.0144	CrCbGaD
Mesoridazine—Propiomazine—CHRM2—epilepsy syndrome	4.13e-05	0.014	CrCbGaD
Mesoridazine—Cyamemazine—HTR2A—epilepsy syndrome	4.02e-05	0.0137	CrCbGaD
Mesoridazine—Promazine—CHRM3—epilepsy syndrome	4.02e-05	0.0137	CrCbGaD
Mesoridazine—Promazine—CHRM1—epilepsy syndrome	3.75e-05	0.0127	CrCbGaD
Mesoridazine—Thioridazine—CHRM2—epilepsy syndrome	3.7e-05	0.0126	CrCbGaD
Mesoridazine—Thioridazine—HTR7—epilepsy syndrome	3.68e-05	0.0125	CrCbGaD
Mesoridazine—Fluphenazine—ADRA2A—epilepsy syndrome	3.66e-05	0.0125	CrCbGaD
Mesoridazine—Chlorpromazine—CHRM3—epilepsy syndrome	3.53e-05	0.012	CrCbGaD
Mesoridazine—Methotrimeprazine—CHRM2—epilepsy syndrome	3.53e-05	0.012	CrCbGaD
Mesoridazine—Promethazine—CHRM2—epilepsy syndrome	3.48e-05	0.0118	CrCbGaD
Mesoridazine—Trifluoperazine—CHRM2—epilepsy syndrome	3.43e-05	0.0117	CrCbGaD
Mesoridazine—Perphenazine—HTR7—epilepsy syndrome	3.38e-05	0.0115	CrCbGaD
Mesoridazine—Eletriptan—CYP2D6—epilepsy syndrome	3.37e-05	0.0115	CrCbGaD
Mesoridazine—Chlorpromazine—CHRM1—epilepsy syndrome	3.3e-05	0.0112	CrCbGaD
Mesoridazine—Mequitazine—CYP2D6—epilepsy syndrome	3.19e-05	0.0109	CrCbGaD
Mesoridazine—Thioridazine—ADRA2A—epilepsy syndrome	3.15e-05	0.0107	CrCbGaD
Mesoridazine—Pipotiazine—CYP2C19—epilepsy syndrome	3.06e-05	0.0104	CrCbGaD
Mesoridazine—Promazine—CHRM2—epilepsy syndrome	3.06e-05	0.0104	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	3.01e-05	0.0102	CrCbGaD
Mesoridazine—Perphenazine—ADRA2A—epilepsy syndrome	2.9e-05	0.00985	CrCbGaD
Mesoridazine—Chlorpromazine—CHRM2—epilepsy syndrome	2.69e-05	0.00916	CrCbGaD
Mesoridazine—Chlorpromazine—HTR7—epilepsy syndrome	2.68e-05	0.00911	CrCbGaD
Mesoridazine—Promazine—ADRA2A—epilepsy syndrome	2.61e-05	0.00888	CrCbGaD
Mesoridazine—Acepromazine—HTR2A—epilepsy syndrome	2.58e-05	0.00879	CrCbGaD
Mesoridazine—Thioproperazine—HTR2A—epilepsy syndrome	2.52e-05	0.00859	CrCbGaD
Mesoridazine—Thiothixene—HTR2A—epilepsy syndrome	2.48e-05	0.00845	CrCbGaD
Mesoridazine—Pipotiazine—HTR2A—epilepsy syndrome	2.48e-05	0.00845	CrCbGaD
Mesoridazine—Eletriptan—ABCB1—epilepsy syndrome	2.41e-05	0.00818	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA2A—epilepsy syndrome	2.3e-05	0.00782	CrCbGaD
Mesoridazine—Thioridazine—CYP2C19—epilepsy syndrome	2.28e-05	0.00776	CrCbGaD
Mesoridazine—Pipotiazine—CYP2D6—epilepsy syndrome	2.27e-05	0.00773	CrCbGaD
Mesoridazine—Thiothixene—CYP2D6—epilepsy syndrome	2.27e-05	0.00773	CrCbGaD
Mesoridazine—Chlorpromazine—BCHE—epilepsy syndrome	2.24e-05	0.00764	CrCbGaD
Mesoridazine—Prochlorperazine—CYP2D6—epilepsy syndrome	2.17e-05	0.00739	CrCbGaD
Mesoridazine—Fluphenazine—HTR2A—epilepsy syndrome	2.15e-05	0.0073	CrCbGaD
Mesoridazine—Perphenazine—CYP2C19—epilepsy syndrome	2.09e-05	0.00712	CrCbGaD
Mesoridazine—Propiomazine—HTR2A—epilepsy syndrome	2.06e-05	0.00703	CrCbGaD
Mesoridazine—Fluphenazine—CYP2D6—epilepsy syndrome	1.96e-05	0.00668	CrCbGaD
Mesoridazine—Promazine—CYP2C19—epilepsy syndrome	1.89e-05	0.00642	CrCbGaD
Mesoridazine—Thioridazine—HTR2A—epilepsy syndrome	1.85e-05	0.00629	CrCbGaD
Mesoridazine—Triflupromazine—ABCB1—epilepsy syndrome	1.82e-05	0.0062	CrCbGaD
Mesoridazine—Acepromazine—ALB—epilepsy syndrome	1.77e-05	0.00601	CrCbGaD
Mesoridazine—Methotrimeprazine—HTR2A—epilepsy syndrome	1.77e-05	0.00601	CrCbGaD
Mesoridazine—Promethazine—HTR2A—epilepsy syndrome	1.74e-05	0.00592	CrCbGaD
Mesoridazine—Thioproperazine—ALB—epilepsy syndrome	1.73e-05	0.00588	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—epilepsy syndrome	1.72e-05	0.00584	CrCbGaD
Mesoridazine—Pipotiazine—ALB—epilepsy syndrome	1.7e-05	0.00578	CrCbGaD
Mesoridazine—Thiothixene—ALB—epilepsy syndrome	1.7e-05	0.00578	CrCbGaD
Mesoridazine—Perphenazine—HTR2A—epilepsy syndrome	1.7e-05	0.00578	CrCbGaD
Mesoridazine—Thioridazine—CYP2D6—epilepsy syndrome	1.69e-05	0.00575	CrCbGaD
Mesoridazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	1.61e-05	0.00549	CrCbGaD
Mesoridazine—Promethazine—CYP2D6—epilepsy syndrome	1.59e-05	0.00541	CrCbGaD
Mesoridazine—Perphenazine—CYP2D6—epilepsy syndrome	1.55e-05	0.00528	CrCbGaD
Mesoridazine—Promazine—HTR2A—epilepsy syndrome	1.53e-05	0.00521	CrCbGaD
Mesoridazine—Fluphenazine—ABCB1—epilepsy syndrome	1.4e-05	0.00477	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2A—epilepsy syndrome	1.35e-05	0.00458	CrCbGaD
Mesoridazine—Chlorpromazine—CYP2D6—epilepsy syndrome	1.23e-05	0.00419	CrCbGaD
Mesoridazine—Promethazine—ABCB1—epilepsy syndrome	1.14e-05	0.00386	CrCbGaD
Mesoridazine—Trifluoperazine—ABCB1—epilepsy syndrome	1.12e-05	0.00381	CrCbGaD
Mesoridazine—Chlorpromazine—ALB—epilepsy syndrome	9.21e-06	0.00314	CrCbGaD
Mesoridazine—Chlorpromazine—ABCB1—epilepsy syndrome	8.79e-06	0.00299	CrCbGaD
Mesoridazine—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	2.6e-06	3.82e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	2.6e-06	3.82e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	2.6e-06	3.82e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	2.58e-06	3.79e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PRKCB—epilepsy syndrome	2.58e-06	3.78e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6ST—epilepsy syndrome	2.57e-06	3.77e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	2.56e-06	3.76e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	2.56e-06	3.75e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	2.55e-06	3.75e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCR5—epilepsy syndrome	2.55e-06	3.75e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	2.54e-06	3.73e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	2.54e-06	3.73e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	2.54e-06	3.72e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	2.53e-06	3.71e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	2.51e-06	3.69e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	2.5e-06	3.67e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR2A—epilepsy syndrome	2.5e-06	3.67e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	2.5e-06	3.66e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	2.49e-06	3.66e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	2.49e-06	3.65e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.49e-06	3.65e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	2.48e-06	3.64e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	2.47e-06	3.63e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	2.46e-06	3.61e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	2.45e-06	3.6e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	2.44e-06	3.58e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.42e-06	3.56e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.41e-06	3.53e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	2.41e-06	3.53e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	2.4e-06	3.52e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.4e-06	3.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	2.39e-06	3.51e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.39e-06	3.51e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	2.39e-06	3.5e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	2.38e-06	3.49e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	2.38e-06	3.49e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TSC2—epilepsy syndrome	2.37e-06	3.48e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	2.37e-06	3.48e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AGT—epilepsy syndrome	2.37e-06	3.48e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	2.36e-06	3.47e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	2.36e-06	3.46e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—POMC—epilepsy syndrome	2.35e-06	3.45e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	2.34e-06	3.43e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	2.34e-06	3.43e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	2.34e-06	3.43e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	2.33e-06	3.42e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—APOE—epilepsy syndrome	2.32e-06	3.41e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	2.32e-06	3.41e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.31e-06	3.39e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	2.3e-06	3.38e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCL2—epilepsy syndrome	2.3e-06	3.37e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	2.3e-06	3.37e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	2.3e-06	3.37e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	2.29e-06	3.36e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.29e-06	3.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	2.28e-06	3.34e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—KDR—epilepsy syndrome	2.28e-06	3.34e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	2.26e-06	3.32e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	2.26e-06	3.31e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.23e-06	3.26e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	2.22e-06	3.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	2.21e-06	3.25e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PRKCB—epilepsy syndrome	2.19e-06	3.21e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6ST—epilepsy syndrome	2.18e-06	3.2e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.18e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	2.17e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	2.17e-06	3.18e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	2.14e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	2.13e-06	3.13e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	2.11e-06	3.1e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	2.11e-06	3.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	2.1e-06	3.08e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	2.1e-06	3.08e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	2.08e-06	3.05e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—FGF2—epilepsy syndrome	2.08e-06	3.05e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	2.07e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.07e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.07e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.07e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.07e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	2.07e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.07e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	2.06e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.06e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	2.06e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	2.06e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	2.04e-06	2.99e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	2.03e-06	2.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.03e-06	2.98e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	2.03e-06	2.98e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.02e-06	2.97e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	2.01e-06	2.95e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	2.01e-06	2.95e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2e-06	2.93e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—POMC—epilepsy syndrome	2e-06	2.93e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.99e-06	2.93e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.98e-06	2.91e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.98e-06	2.9e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.97e-06	2.89e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.97e-06	2.89e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.97e-06	2.88e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.96e-06	2.88e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.95e-06	2.87e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	1.95e-06	2.86e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.94e-06	2.85e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	1.94e-06	2.85e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.94e-06	2.84e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—RELA—epilepsy syndrome	1.93e-06	2.83e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.92e-06	2.82e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.92e-06	2.81e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.91e-06	2.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.91e-06	2.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.9e-06	2.79e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.9e-06	2.79e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.89e-06	2.78e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	1.89e-06	2.77e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	1.89e-06	2.77e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.88e-06	2.75e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	1.85e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.82e-06	2.66e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.81e-06	2.66e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.79e-06	2.62e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.79e-06	2.62e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.78e-06	2.62e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.78e-06	2.61e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.78e-06	2.61e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	1.76e-06	2.59e-05	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	1.76e-06	2.58e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	1.75e-06	2.57e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	1.75e-06	2.57e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.75e-06	2.57e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.75e-06	2.56e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.74e-06	2.55e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	1.74e-06	2.55e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.74e-06	2.55e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.73e-06	2.54e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	1.72e-06	2.52e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.71e-06	2.51e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.71e-06	2.51e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.7e-06	2.5e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.69e-06	2.48e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—JUN—epilepsy syndrome	1.69e-06	2.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	1.68e-06	2.47e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.68e-06	2.46e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.67e-06	2.45e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.65e-06	2.42e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.65e-06	2.41e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	1.64e-06	2.41e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.64e-06	2.41e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.64e-06	2.4e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.64e-06	2.4e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	1.62e-06	2.38e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.62e-06	2.37e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	1.61e-06	2.37e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.61e-06	2.36e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.6e-06	2.34e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	1.59e-06	2.34e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.55e-06	2.28e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.54e-06	2.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.53e-06	2.24e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.53e-06	2.24e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	1.52e-06	2.22e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.5e-06	2.2e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.5e-06	2.2e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.49e-06	2.19e-05	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.49e-06	2.19e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	1.48e-06	2.17e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	1.48e-06	2.17e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	1.48e-06	2.16e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.47e-06	2.16e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.47e-06	2.15e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	1.44e-06	2.12e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.44e-06	2.12e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	1.44e-06	2.11e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.43e-06	2.09e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.42e-06	2.08e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.4e-06	2.05e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	1.4e-06	2.05e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.39e-06	2.04e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	1.35e-06	1.99e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.35e-06	1.98e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.33e-06	1.95e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	1.33e-06	1.94e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.3e-06	1.91e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.3e-06	1.91e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.29e-06	1.9e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.29e-06	1.89e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	1.29e-06	1.89e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.28e-06	1.88e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.27e-06	1.86e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	1.25e-06	1.84e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.25e-06	1.84e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.25e-06	1.83e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.24e-06	1.83e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.24e-06	1.82e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.23e-06	1.81e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	1.23e-06	1.81e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.23e-06	1.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.22e-06	1.79e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.21e-06	1.78e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	1.21e-06	1.78e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.21e-06	1.77e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	1.21e-06	1.77e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.19e-06	1.74e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.18e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.17e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.14e-06	1.67e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.13e-06	1.66e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.12e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.12e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.12e-06	1.64e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.12e-06	1.64e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.11e-06	1.63e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	1.11e-06	1.63e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.1e-06	1.62e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.1e-06	1.61e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.09e-06	1.6e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-06	1.6e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.09e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.08e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	1.08e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.07e-06	1.57e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.07e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.06e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.05e-06	1.54e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	1.05e-06	1.54e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.04e-06	1.52e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-06	1.51e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.02e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.02e-06	1.49e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1e-06	1.47e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	9.85e-07	1.45e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.71e-07	1.42e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	9.69e-07	1.42e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	9.67e-07	1.42e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	9.59e-07	1.41e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	9.52e-07	1.4e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	9.44e-07	1.38e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	9.42e-07	1.38e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	9.42e-07	1.38e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	9.27e-07	1.36e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.5e-07	1.25e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	8e-07	1.17e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	6.97e-07	1.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	6.94e-07	1.02e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	6.12e-07	8.98e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	6.02e-07	8.84e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	6.01e-07	8.82e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	5.91e-07	8.68e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.27e-07	6.26e-06	CbGpPWpGaD
